How old is your son today? Afrezza is an amazing product. It was sandbagged by Sanofi and MannKind has taken over their own marketing. Its just been Re-launched in July 2016. Users report lowered A1C measurements and great BG levels.
I will be watching, but it will have to be approved for Type I’s first I would imagine. For insulin resistant folks, the Type II’s, this is probably the elixir.
Though they are both called diabetes, the two disease are wildly different. In Type I’s, the pancreas doesn’t produce insulin, period, not even basal.
As such, you would have to supplement with Lantus I would imagine.
For sick day management, when the kid can’t hold down food because he’s 850 and throwing ketones, this would be the cat’s meow.
We’ll see what the endocrinologists have to say in the next few months.
There were a couple of Canadian doctors that used capscasin to treat the pancreas and get it secreting again. They pretty much went off the grid.
That’s the thing about cures: the only money you can make with them is blackmailing the companies providing the leading treatment and mitigation strategies with it.
Novo Nordisks 10K actually states that producing insulin is what they do. The mission statement says zero about curing diabetes, for example.
Were a Novo CEO actually to suggest finding a cure, they would find him in Rock Creek under the same tree they found Foster.